Skip to main content
Skip to main content
AMFPF logo

Amplifon S.p.A. (AMFPF) Stock Analysis

$11.21 +$0.00 (+0.00%) |CouncilSplit View · 36 · D
Amplifon S.p.A. (AMFPF) bottom line: Split View — our Council read (36/100) and AI Score (38/100) broadly agree. Strongest single signal: Izzy Englander bearish.
MCap: $2.97B| P/E Ratio: 34.6| Vol: 300| 52-wk range: $10.28 – $23.85
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Amplifon S.p.A. (AMFPF) trades at $11.21 with AI Score 38/100 (Grade D). Amplifon S. p. A. Market cap: $2.97B, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: Mar 18, 2026
Amplifon S.p.A. is a global leader in hearing care solutions, providing a range of products and services to address hearing loss. The company operates through a network of retail stores and service centers, offering personalized hearing solutions and audiological care.

Analyst Coverage for AMFPF: AMFPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMFPF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the AMFPF film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 36/100 · D

AMFPF: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Bearish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Amplifon S.p.A. (AMFPF) Healthcare & Pipeline Overview

HeadquartersMilan, Italy

Amplifon S.p.A. is a global leader in hearing care solutions, offering a wide range of hearing devices and audiological services across Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company differentiates itself through personalized customer care and innovative product offerings, addressing a growing global need.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for AMFPF?

As of Mar 18, 2026 — figures reflect the data available on that date.

Amplifon S.p.A. presents a notable research candidate due to its leading position in the growing hearing care market. The company's global presence and diverse product portfolio provide a strong foundation for continued growth. With an aging global population and increasing awareness of hearing loss, the demand for hearing solutions is expected to rise, benefiting Amplifon. The company's focus on innovation and personalized customer care further enhances its competitive advantage. However, investors may want to evaluate the company's high debt-to-equity ratio of 195.11 and the potential impact of regulatory changes on the hearing care industry. The company's profit margin of 3.8% and ROE of 8.6% also warrant careful consideration.

Based on FMP financials and quantitative analysis

AMFPF Key Highlights

Market Cap of $2.97B reflects Amplifon's significant presence in the hearing care market.

  • Profit Margin of 3.8% indicates areas for potential improvement in operational efficiency.
  • Gross Margin of 22.6% demonstrates the company's ability to generate revenue from its products and services.
  • Return on Equity (ROE) of 8.6% shows the company's profitability relative to shareholder equity.
  • Debt-to-Equity Ratio of 195.11 suggests a high level of financial leverage, which could pose risks.

Who Are AMFPF's Competitors?

AMFPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
PDCO Patterson Companies, Inc. $31.33 -0.90% $2.77B 42
ALFRY Alfresa Holdings Corporation $13.55 +0.00% $2.46B 49
PBH Prestige Consumer Healthcare Inc. $50.52 -2.24% $2.39B 64
GRDN Guardian Pharmacy Services, Inc. $37.48 -1.29% $2.37B 96
MEPDF MediPal Holdings Corporation $18.35 +0.00% $3.76B 49
MAHLY MediPal Holdings Corporation $18.50 +6.51% $3.79B 48
CAKFY McKesson Europe AG $4.10 +0.00% $5.37B 35
SHPMY Shanghai Pharmaceuticals Holding Co., Ltd $7.47 +0.00% $5.54B 40

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMFPF's Key Strengths?

Global presence and extensive retail network.

  • Strong brand reputation and customer loyalty.
  • Diverse product portfolio and technological innovation.
  • Focus on personalized customer care.

What Are AMFPF's Weaknesses?

High debt-to-equity ratio.

  • Profit margin lower than some competitors.
  • Dependence on retail sales.

What Could Drive AMFPF Stock Higher?

Launch of new hearing device models with advanced features in Q4 2026.

  • Expansion of the Ampli-care platform to new geographic regions throughout 2026.
  • Strategic partnerships with healthcare providers to increase patient referrals.

What Are the Key Risks for AMFPF?

Rich valuation — a P/E of 34.6 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.

  • Increased competition from new entrants in the hearing care market.
  • Regulatory changes affecting the pricing and distribution of hearing aids.
  • Economic downturns impacting consumer spending on healthcare products and services.
  • Fluctuations in currency exchange rates affecting international sales.

What Are the Growth Opportunities for AMFPF?

  • Expansion in Emerging Markets: Amplifon has the opportunity to expand its presence in emerging markets, such as Asia Pacific and Latin America, where the demand for hearing care solutions is growing rapidly. These markets offer significant growth potential due to their large populations and increasing awareness of hearing loss. By establishing new retail stores and service centers in these regions, Amplifon can tap into a new customer base and increase its global market share. This expansion could contribute significantly to revenue growth over the next 3-5 years.
  • Technological Innovation: Amplifon can drive growth by investing in research and development to develop innovative hearing solutions that meet the evolving needs of its customers. This includes developing advanced hearing devices with improved sound quality, connectivity, and user-friendly features. By staying at the forefront of hearing technology, Amplifon can attract new customers and retain existing ones. The company's Ampli-care platform and Amplifon App demonstrate its commitment to technological innovation, which can be further leveraged to drive growth.
  • Strategic Acquisitions: Amplifon can pursue strategic acquisitions to expand its market share and geographic reach. By acquiring smaller hearing care companies or audiology clinics, Amplifon can quickly gain access to new markets and customer bases. Acquisitions can also provide access to new technologies and expertise, further enhancing Amplifon's competitive advantage. The company has a history of successful acquisitions, which can be replicated to drive future growth.
  • Partnerships with Healthcare Providers: Amplifon can partner with healthcare providers, such as hospitals and clinics, to offer its hearing care solutions to a wider audience. By integrating its services into the healthcare system, Amplifon can reach patients who may not be aware of their hearing loss or the available treatment options. These partnerships can also provide access to valuable patient data, which can be used to improve the effectiveness of Amplifon's products and services. This collaborative approach can drive growth and improve patient outcomes.
  • Focus on Personalized Customer Care: Amplifon can differentiate itself from competitors by focusing on providing personalized customer care. This includes offering customized hearing solutions that meet the specific needs of each customer, as well as providing ongoing support and maintenance. By building strong relationships with its customers, Amplifon can increase customer loyalty and generate repeat business. The company's Ampli-care platform is designed to enhance the audiological care experience, which can be further leveraged to drive growth.

What Are AMFPF's Competitive Advantages?

  • Extensive global network of retail stores and service centers.
  • Strong brand reputation and customer loyalty.
  • Focus on personalized customer care and audiological services.
  • Technological innovation in hearing devices and digital solutions.

What Does AMFPF Do?

Founded in 1950 and headquartered in Milan, Italy, Amplifon S.p.A. has evolved into a leading global provider of hearing solutions and services. The company's core business revolves around the distribution and fitting of customized hearing devices, designed to help individuals rediscover the emotions of sound. Amplifon operates a vast network of retail stores and service centers across Europe, the Middle East, Africa, the Americas, and the Asia Pacific regions, ensuring accessibility and personalized care for its customers. Amplifon's product portfolio includes a diverse range of hearing devices, such as Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini, catering to various hearing needs and preferences. The company also offers Ampli-care, a platform designed to enhance the audiological care experience, and the Amplifon App, which allows users to manage device functions directly from their smartphones. These innovations reflect Amplifon's commitment to leveraging technology to improve the customer experience and provide advanced hearing solutions. Through its extensive global presence and customer-centric approach, Amplifon has established a strong brand reputation and a loyal customer base. The company continues to invest in research and development to stay at the forefront of hearing technology and expand its product offerings. Amplifon's commitment to innovation and personalized care positions it as a key player in the growing hearing care market.

What Products and Services Does AMFPF Offer?

  • Distributes hearing solutions across Europe, the Middle East, Africa, the Americas, and the Asia Pacific.
  • Fits customized hearing products to address individual hearing loss needs.
  • Operates Ampli-care, a platform for delivering audiological care.
  • Offers the Amplifon App for smartphone management of hearing device functions.
  • Provides a range of hearing devices including Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini.
  • Manages a network of retail stores and service centers for accessibility.

How Does AMFPF Make Money?

  • Sells hearing devices and related accessories through its retail network.
  • Provides audiological services, including hearing tests and device fitting.
  • Generates revenue from after-sales services, such as maintenance and repairs.
  • Offers digital solutions, such as the Amplifon App, to enhance customer experience.

What Industry Does AMFPF Operate In?

Amplifon operates within the medical distribution industry, specifically focusing on hearing care solutions. The industry is driven by factors such as an aging global population, increasing awareness of hearing loss, and technological advancements in hearing devices. The competitive landscape includes other hearing aid manufacturers, retailers, and audiology clinics. Amplifon's extensive global network and focus on personalized customer care differentiate it from competitors. The global hearing aid market is expected to continue growing, driven by the increasing prevalence of hearing loss and the demand for advanced hearing solutions.

Who Are AMFPF's Key Customers?

  • Individuals experiencing hearing loss.
  • Healthcare providers and audiologists.
  • Government and private healthcare systems.
  • Individuals seeking preventative hearing care.
AI Confidence: 66% Updated: Mar 18, 2026

Company Profile

Amplifon S.p.A. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Milan, IT. The company is led by CEO Enrico Vita. AMFPF has traded publicly since 2003.

ROE 7%

Key Financial Metrics

Return on equity for Amplifon S.p.A. stands at 6.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.8%, showing how much profit it generates from its asset base. AMFPF trades at a trailing price-to-earnings ratio of 34.65, above the Healthcare sector average of ~23x. Its free cash flow yield is 6.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.47 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 2.9%, the inverse of the P/E and a quick read on earnings relative to price.

AMFPF Valuation & Market Position

With a $2.97B market cap, Amplifon S.p.A. sits in the mid-cap segment of the market. Relative to its peer group, AMFPF's quantitative score of 38/100 is below the peer average of 60/100.

Quarterly Financial Performance: Amplifon S.p.A.

Revenue for Amplifon S.p.A. came in at $605.1M during Q2 2026, a 4.0% improvement versus the preceding quarter. The company recorded net income of $38.5M, with diluted EPS of $0.14. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, AMFPF averaged $0.07 in diluted EPS.

F-Score 6/9

Financial Health

Amplifon S.p.A.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.88 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 est

Forward Outlook

Wall Street analysts project Amplifon S.p.A. revenue of about $2.45B for fiscal 2026, with EPS near $0.71. The estimate reflects 7 contributing analysts.

AMFPF Financials

Fundamental Snapshot

Revenue Growth (FY)
-0.6%
Net Income Growth (FY)
-37.2%
EPS Growth (FY)
-37.5%
Free Cash Flow Growth (FY)
-2.7%
P/E (TTM)
34.6
Return on Equity (TTM)
+6.8%
Current Ratio
0.5
EV/EBITDA (TTM)
7.8

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Global presence and extensive retail network.
  • Strong brand reputation and customer loyalty.
  • Diverse product portfolio and technological innovation.
  • Focus on personalized customer care.

Bear Case

  • High debt-to-equity ratio.
  • Profit margin lower than some competitors.
  • Dependence on retail sales.
  • Potential: Increased competition from new entrants in the hearing care market.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $605M $38M $0.14
Q1 2026 $582M $11M $0.05
Q4 2025 $652M $17M $0.07
Q3 2025 $564M $6M $0.03

Based on FMP financials and quantitative analysis

AMFPF Latest News

No recent news available for AMFPF.

AMFPF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMFPF.

Price Targets

Wall Street price target analysis for AMFPF.

AMFPF MoonshotScore

38/100

What does this score mean?

The MoonshotScore rates AMFPF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

AMFPF OTC Market Information

AMFPF trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

AMFPF Healthcare Stock FAQ

What does the AI Score mean for AMFPF?

AMFPF holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Amplifon S.p.A. is a global leader in hearing care solutions, providing a range of products and services to address hearing loss. The company operates through a network of retail stores and service …

What does Amplifon S.p.A. do?

Amplifon S.p.A. is a global leader in the hearing care industry, specializing in the distribution and fitting of hearing solutions. The company operates through an extensive network of retail stores and service centers, providing personalized audiological care and a wide range of hearing devices to individuals with hearing loss.

What do analysts say about AMFPF stock?

Analyst coverage of AMFPF is currently limited, but industry reports suggest a positive outlook for the hearing care market. Key valuation metrics, such as price-to-earnings ratio and enterprise value-to-EBITDA, are not readily available due to the stock's OTC status.

What are the main risks for AMFPF?

Amplifon faces several risks, including intense competition from other hearing aid manufacturers and retailers, regulatory changes affecting the pricing and distribution of hearing aids, and economic downturns impacting consumer spending on healthcare products and services. The company's high debt-to-equity ratio also poses a financial risk. Additionally, fluctuations in currency exchange rates could affect international sales. Investors should carefully consider these risks before investing in AMFPF.

What are the key factors to evaluate for AMFPF?

Amplifon S.p.A. (AMFPF) holds an AI score of 38/100 (low). P/E: 34.6x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does AMFPF data refresh on this page?

AMFPF's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven AMFPF's recent stock price performance?

Amplifon S.p.A. (AMFPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global presence and extensive retail network. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AMFPF overvalued or undervalued right now?

Amplifon S.p.A. (AMFPF) trades at 34.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research AMFPF before investing?

Before investing in Amplifon S.p.A. (AMFPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited analyst coverage for AMFPF due to its OTC status.
  • Financial data based on available sources and may not be fully comprehensive.
Data Sources

Popular Stocks

More Stocks We Cover